Sex hormone-binding globulin
Cross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Sex hormone-binding globulin as ChEMBL target CHEMBL3305, mapped to UniProt P04278. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Why Sex hormone-binding globulin matters
Sex hormone-binding globulin is reviewed as Sex hormone-binding globulin (UniProt P04278); the current evidence base includes 17 approved drugs, 179 compounds, and 33 assays, with lead potency reaching pChEMBL 9.7.
Sex hormone-binding globulin Sequence length is 402 aa.
Review this target as Sex hormone-binding globulin, mapped to UniProt P04278. Sequence length is 402 aa.
Protein source · UniProt accession via ChEMBL component mappingDisease relevance is not yet populated for this evidence card.
This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
ChEMBL target recordChEMBL currently tracks 17 approved drugs, 179 compounds, and 33 assays for this target. The dominant activity type is KD. CHEMBL260202 is the current potency anchor at pChEMBL 9.7.
Use CHEMBL260202 as the tractability anchor when discussing potency (pChEMBL 9.7).
Activity source · ChEMBL 36 via Core EngineStart with the right source
Pick the first block or linked source that matches the review question in front of you.
Start with the review rationale when you need to explain why Sex hormone-binding globulin matters before drilling into raw source blocks.
Jump to Review RationaleGo back to the target snapshot when you need the naming and mapping contract behind UniProt P04278, not just the summarized rationale.
Open Protein ContextUse the target snapshot disease block when you need the disease program and supporting signals, not only the card summary.
Open Disease ContextSnapshot State
No project snapshot selected. Export uses the live evidence card state.
pChEMBL Activity Distribution
Top 5 Inhibitors (by pChEMBL)
| Structure | Compound | pChEMBL | Type | Phase |
|---|---|---|---|---|
|
|
No preferred name
CHEMBL260202
|
9.7 | Kd | — |
|
|
No preferred name
CHEMBL27769
|
9.7 | Kd | Clinical |
|
|
No preferred name
CHEMBL258918
|
9.6 | Kd | Clinical |
|
|
No preferred name
CHEMBL259126
|
9.5 | Kd | — |
|
|
No preferred name
CHEMBL411053
|
9.4 | Kd | — |
Approved Drugs
| Structure | Compound | First Approval |
|---|---|---|
|
|
ETONOGESTREL
CHEMBL1531
|
2001 |
|
|
ESTRIOL
CHEMBL193482
|
2000 |
|
|
DESOGESTREL
CHEMBL1533
|
1992 |
|
|
ETHINYL ESTRADIOL
CHEMBL691
|
1982 |
|
|
ESTRONE
CHEMBL1405
|
1979 |
|
|
DANAZOL
CHEMBL1479
|
1976 |
|
|
PROGESTERONE
CHEMBL103
|
1976 |
|
|
ESTRADIOL
CHEMBL135
|
1975 |
|
|
METHYLTESTOSTERONE
CHEMBL1395
|
1973 |
|
|
TESTOSTERONE
CHEMBL386630
|
1972 |
|
|
NORGESTREL
CHEMBL2107797
|
1968 |
|
|
NORETHINDRONE
CHEMBL1162
|
1962 |
|
|
MEDROXYPROGESTERONE ACETATE
CHEMBL717
|
1959 |
|
|
HYDROCORTISONE
CHEMBL389621
|
1952 |
|
|
PRASTERONE
CHEMBL90593
|
— |